All sites C00-96,D32-33,D42-43,D45-47,D76 487 86.9 4.6 3.4 0.6 4.5
Mouth, pharynx C00-14 13 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 6 100.0 - - - -
Digestive organs C15-26 101 79.7 4.4 6.4 1.4 8.2
  Oesophagus C15 7 88.6 2.9 - - 8.6
  Stomach C16 13 96.8 - - - 3.2
  Small intestine C17 2 88.9 - - - 11.1
  Colon C18 27 95.6 - 0.7 - 3.7
  Rectum, rectosigmoid C19-20 21 99.0 - - 1.0 -
  Anus C21 0 100.0 - - - -
  Liver C22 9 43.2 20.5 18.2 2.3 15.9
  Gallbladder, bile ducts C23-24 5 77.8 11.1 7.4 - 3.7
  Pancreas C25 16 30.8 11.5 24.4 6.4 26.9
  Other digestive organs C26 1 40.0 - 40.0 - 20.0
Respiratory organs C30-39 66 66.5 21.8 8.5 0.6 2.7
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 4 100.0 - - - -
  Lung, trachea C33-34 60 63.9 23.8 8.6 0.7 3.0
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 16 100.0 - - - -
Skin, non-melanoma C44 26 100.0 - - - -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 3 92.9 - 7.1 - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 134 99.0 - - - 1.0
  Prostate C61 129 99.1 - - - 0.9
  Testis C62 4 94.4 - - - 5.6
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 41 94.2 1.9 2.9 - 1.0
  Kidney C64 13 89.4 1.5 7.6 - 1.5
  Bladder and urinary tract2 C65-68 28 96.4 2.1 0.7 - 0.7
Eye C69 0 - - 100.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 14 90.3 - 6.9 - 2.8
Thyroid gland C73 4 94.4 5.6 - - -
Other endocrine glands C74-75 1 66.7 - - - 33.3
Illdefined or unknown C76,C80 8 45.0 5.0 20.0 7.5 22.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 57 80.9 3.9 0.7 0.7 13.8
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 26 94.6 3.1 - - 2.3
  Malignant immunoproliferative diseases C88 1 80.0 - - - 20.0
  Myeloma and other plasma cell tumors C90 7 75.8 15.2 3.0 3.0 3.0
  Leukaemia C91-95 11 61.4 3.5 1.8 1.8 31.6
  Myelodysplastic syndromes D46 3 21.4 - - - 78.6
  Myeloproliferaitive neoplasms D45,D47 6 83.9 - - - 16.1
Not included above
  Basal cell carcinoma of the skin 142 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.